H.GrayE
& Kim, M.-S
Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D
Results from observational, target trial emulation, Mendelian randomization, and preliminary controlled studies have reported benefits with GLP-1 RAs across multiple clinical targets including alcohol-,substance- and tobacco-use disorders, mood and psychotic disorders, binge-eating disorder, and major neurocognitive disorders
Poor eating choices can counteract medication benefits, leading to nutrient deficiencies, muscle loss, or digestive issues
Regarding the testosterone experiment, the arbitration panel noted that it was conducted at a well known training facility with no actual justification and involving the administration of a controlled substance in potential violation of federal laws. The panel also noted that Mark Parker, the CEO of Nike, was kept abreast of the experiment